Evidence map›Paper›PMID 32300397›Full record

ArticleJournal of hematology2017

The

Jose Pereira de Moura Neto, Bruno Antonio Veloso Cerqueira, Wendell Vilas Boas Santos, Isa Menezes Lyra, Marilda Souza Goncalves

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of hematology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 85% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Transfusion support for a woman withImmunohematology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Jose Pereira de Moura NetoFaculdade de Farmacia, Universidade Federal do Amazonas, Manaus, Amazonas, Brazil.
Bruno Antonio Veloso CerqueiraDepartamento de Ciencias da Vida, Universidade do Estado da Bahia, Salvador, Bahia, Brazil.
Wendell Vilas Boas SantosFaculdade de Farmacia, Universidade Federal do Amazonas, Manaus, Amazonas, Brazil.
Isa Menezes LyraUniversidade Federal da Bahia, Salvador, Bahia, Brazil.
Marilda Souza GoncalvesFundacao Oswaldo Cruz - Centro de Pesquisas Goncalo Moniz, Salvador, Bahia, Brazil.
Universidade Federal da Bahia · BRUniversidade Federal do Amazonas · BRUniversidade do Estado da Bahia · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAntigens DIIIa, DAR and DAU are common in people of African descent and are involved in anti-D alloimmunization. Sickle cell disease (SCD) patients frequently need blood therapy and are vulnerable to alloimmunization.

methodsThe study included SCD patients from the Brazilian state of Bahia, which has the highest incidence of the disease in Brazil; 241 SCD patients and 220 healthy individuals were studied. Alleles were characterized by PCR-RFLP and PCR-SSP techniques.

resultsThe

conclusionThere was statistical significance when the allele frequencies were evaluated among SCD, sickle cell anemia (HbSS) patients and healthy individuals. The frequencies of the

Indexed as

Anti-D alloimmunizationDARDAU allelesDIIIaSickle cell disease

Identifiers

PMID32300397
PMCPMC7155847
OpenAlexW2755741715

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.